Lineage Cell Therapeutics, Inc. (LCTX) — Analyst estimates
Consensus analyst estimates for Lineage Cell Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 15.93M | -0.07 | 5 |
| 2027 | 10.35M | -0.09 | 5 |
| 2028 | 46.14M | 0.01 | 5 |
| 2029 | 123.76M | 0.22 | 1 |
| 2030 | 470.98M | 1.43 | 1 |
Consensus analyst estimates by fiscal year.